When looking for large health care dividends, investors are primarily limited to large pharma stocks. However, there are a few exceptions, including a brand new dividend payer in Questcor Pharmaceuticals (NASDAQ:QCOR). Questcor isn't your run-of-the-mill defensive health care stock -- shares are dealing with multiple headwinds that could impact the sustainability of this payout in the long term.

In the following video, health care bureau chief Brenton Flynn outlines these headwinds, as well as his opinion on what type of investor should be looking to buy Questcor relative to a more stable big pharma dividend stock like Pfizer or Johnson & Johnson.

Brenton Flynn has no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.